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Abstract
Background: Sepsis is a life-threatening condition that can lead to septic shock and
death. With over 300,000 annual cases (AHRQ, 2011) costing a staggering $1.5 billion
(Health Care Utilization Project Brief #185), the importance of sepsis is becoming clear.
However, some basic biological mechanisms are poorly understood.
Study Purpose: This study investigated the relationships between select demographics,
resting energy expenditure (REE), serum lactate, SOFA score mortality index, oxygen
consumption [by way of measuring net oxygen consumed, (V02) and net carbon dioxide
produced (VC02)], and sepsis.
Specific Aims: Aims were to describe 1) patient demographics, serum lactate, SOFA
score mortality index, sepsis diagnosis, and 02 consumption; 2) the difference in oxygen
consumption in ICU patients with and without a diagnosis of sepsis; 3a) the relationships
between gender, age, REE, height, weight, lactate and VO2; 3b) the relationships
between gender, age, REE, height, weight, lactate and VCO2; and 4) the relationships
between age, gender, height, weight, VO2, VCO2, lactate, SOFA, REE, and sepsis
Methods: Data for this quantitative descriptive feasibility study were accessed from two
hospital databases.
Results: For the total cases (N = 21) mean age was 71.2 years (+/- 14.1) and mostly
female (71.4%). There was a difference in oxygen consumption between the two groups
of cases (sepsis and non-sepsis) [VO2 (t 3.919, p<0.001); VCO2 (t 3.238, p<0.007)].
Strong relationships were found between VO2 and REE (r = .540, p=0.011), and sepsis
(η = .670, p = 0.001); between VCO2 and weight (r = .619, p = 0.003), REE (r = .669,
p = 0.001) and sepsis (η = .608, p = 0.003); and between sepsis and V02 (η = 670, p =

0.001), VC02
(η = 608, p = 0.003), and lactate (η = 621, p = 0.003).
Implications: Nurses are at the forefront of monitoring patients with sepsis. While this
study utilized a small sample size, significant relationships were found among a number
of important clinical variables. Further research is needed utilizing larger samples to test
predictive models for sepsis so that nurses can intervene to prevent the deterioration of
these patients.
keywords: mitochondrial dysfunction; sepsis; sepsis definition; cytopathic
hypoxia; downregulation; nicotinamide adenine dinucleotide; electron transport chain
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CHAPTER ONE
INTRODUCTION
Overview of the Problem
In the United States sepsis results in 146,000-381,000 deaths) and costs $23.7
billion dollars per year (Torio & Moore, 2016). Over the years, advancements have been
made to decrease deaths and cost. Evidence-based standard assessments and treatments
have been ‘bundled’ together by The Centers for Medicaid and Medicare Services (CMS)
to help hospitals improve mortality and morbidity as well as the costs of sepsis. The
current criteria used by clinicians as part of their clinical decision-making for sepsis
identification are well documented in the literature to be overly sensitive and underspecific (Singer et al., 2016). This leads to an over-identification of affected individuals,
subjecting them to the risks of unnecessary treatment.
Sepsis remains a significant critical issue for hospitals due to the potential for
high mortality rates. At a critical point in the progress of sepsis, patients are unable to
adequately saturate bodily tissues with oxygen. Oxygen consumption, if utilized as a
clinical indicator, may provide evidence that sepsis is present and even becoming a
serious issue. While new technologies allow for oxygen consumption to be measured for
the purposes of determining the needs of the critically ill patient, it is unknown if having
such a measure would contribute to the quality of clinical decision-making, nursing care,
and the associated outcomes of that care. As nurses are held accountable for nurse
sensitive indicators outlined by CMS, any condition that is monitored by CMS impacts
accountability for professional practice. Additionally, awareness of gaps in nursing
practice is the necessary platform needed to design studies that have the potential to
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improve practice and patient outcomes. Therefore, research on oxygen consumption as it
may or may not be related to sepsis is warranted.
This chapter will provide a definition of sepsis and address incidence, risk factors,
current recommended treatments (CMS bundle), and ongoing challenges for managing
sepsis in the critically ill patient. Additionally, the study problem statement, purpose,
specific aims, conceptual framework and methods will be provided to introduce the
reader to the study. This chapter will conclude with a discussion on the potential
significance of the study.
Background
Sepsis
Until 2016, sepsis was merely understood to be a systemic response to infection.
More recently, sepsis is better understood to be a complex syndrome of a dysregulated
host response to any numerous types of infections (Singer et al. 2016). The underlying
pathology of sepsis and causation remains uncertain. However, an inflammatory response
to illness is one of several hypotheses (Urden, Stacy, & Lough, 2014, p904).
In 2001, a study was published by Dr. Emmanuel Rivers recommending Early
Goal Directed Therapy (EGDT) for sepsis. Early Goal Directed Therapy is guided by
fluid resuscitation and oxygen delivery targeting goals of maintaining blood pressure and
serum oxygenation (Rivers et al., 2001). Early Goal Directed Therapy was endorsed by
The Society for Critical Care Medicine (SCCM) partnering with the Surviving Sepsis
Campaign (SSC) to develop inclusion criteria for identification of an inflammatory
response syndrome and to establish criteria to guide EGDT for sepsis treatment (Levy et
al, 2003).
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Per the SSC, sepsis criteria include two or more of the indicators of the Systemic
Inflammatory Response Syndrome (SIRS) in the presence of confirmed or suspected
infection. The SIRS criteria include:
Temperature >38C or <36C
Heart Rate >90bpm
Respiratory Rate >20/min
White Blood Cell Count >12,000/ml or <4,000/ml or >10% immature bands
Therefore, infection in the presence of the SIRS response was then known as sepsis (Bone
et al., 1992).
Sepsis Costs
Costs of sepsis include loss of life as well as treatment expenditures. Despite
recommendations for goal directed therapy, mortality remains 25%-30% and 40%-50%
when patients present with shock (Cohen, 2015).
Patients hospitalized for sepsis often need the highest level of care. Over half
(51%) of sepsis cases require admission to the Intensive Care Unit (ICU) (Angus & Van
der Poll, 2013). Patients have multi-system involvement needing close monitoring for
early signs of decline, and often need the support of mechanical ventilation (Angus &
Van der Poll, 2013). This level of care is the most expensive care in the hospital,
averaging $45,000 per case (Pfuntner, 2011).
Risk Factors for Sepsis
There is mixed evidence in the literature about what actually qualifies as a risk
factor for sepsis. According to the Sepsis Alliance, age (very young and very old),
immunosuppression, and comorbidity tend to make patients be at increased risk for
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sepsis. Additional patients at risk are those with burns, indwelling/invasive medical
devices (e.g., dental and orthopedic prosthesis) or equipment (e.g., Foley catheters,
central lines) (Sepsis Alliance, 2018.). However, there is no published evidence of causal
relationships between these risk factors and sepsis.
In a sepsis case review of the National Hospital Discharge Survey (NHDS)
dataset it was determined that 33% of cases had respiratory infections and 32% of cases
had genitourinary infections (Esper et al., 2006). Males more often had a respiratory
condition versus females (p<0.01) and females more often had a genitourinary condition
versus males (p<0.01).
In another study, respiratory infections were present in 35% of the sepsis cases
followed by genitourinary infection at 25% (Novosad et al., 2016). Per the Centers for
Disease Control and Prevention (CDC), respiratory infection and genitourinary infection
are two of the most common infections present when patients are admitted to hospital,
suggesting an association with sepsis; however, no causal relationships have been
determined by reviewing the literature (Hall, 2011).
A large majority (48%-59%) of cases were reported to have gram positive
bacteria. However, cases of sepsis have also been known to be associated with all forms
of pathogenic microorganisms (Novosad et al., 2016). This analysis also included the
type of comorbid conditions associated with race; persons of non-White races with sepsis
having more comorbid conditions such as diabetes, human immunodeficiency virus
(HIV), chronic renal failure, and alcohol abuse. Persons of the White race with sepsis
cases had more diagnoses of cancer and chronic obstructive pulmonary disease (COPD).
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Actual causative factors may be numerous involving many mediating and
moderating contributors requiring sophisticated research methods that have yet to be
utilized in such vulnerable populations of patients. However, designing studies such as
randomized clinical trials to prospectively test actual causative factors would be unethical
in human subjects’ research.
Incidence of Sepsis and Comorbities
The incidence of sepsis has risen dramatically since the early 1990s when the
SCCM first began to describe the syndrome. The incidence has been difficult to
determine for at least two decades.
Without a gold standard for sepsis identification, diagnosis has been providerdependent. For this reason, sepsis cases are difficult to track and incidence is difficult to
determine. Estimates of cases are derived from multiple sources, such as claims, death
certificates, and International Classification of Diseases (ICD) codes.
One 2006 retrospective analysis of distribution of sepsis cases was conducted
using the National Hospital Discharge Survey (NHDS) dataset (Esper et al., 2006). Data
captured in the dataset included demographic data, diagnostic codes (ICD) for sepsis, and
procedural codes. The 25-year long dataset captured 12,505,082 cases of sepsis.
The Effect of Sepsis upon Organ Systems
Any number of organ systems can be affected by sepsis. Particularly vulnerable
systems include the following: respiratory, cardiovascular, central nervous, digestive, and
genitourinary.
Respiratory system. In sepsis, involvement of the respiratory system pertains to
ventilation occurring in the lungs and cellular respiration occurring within the
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mitochondria of the cell. Manifestations of sepsis with respiratory system involvement
include shortness of breath and may require supplemental oxygen to maintain partial
pressure of dissolved oxygen in the arterial circulation (Pa02). Shortness of breath may
progress to respiratory failure due to acute respiratory distress syndrome (ARDS), as
evidence by bilateral infiltrates and Pa02 over fi02 (fraction of inspired oxygen) or (P/f)
ratio, of <300 (requires arterial blood gas for evaluation). Acute respiratory distress
syndrome can be triggered in sepsis by endovascular injury from cytokine release during
the inflammatory process. Respiratory failure requires mechanical ventilation, guided by
ongoing evaluation of arterial blood gas targeted at improving Pa02. Steroids are not
shown to be of benefit when sepsis compromises the respiratory system and should be
avoided due to the risk of immune suppression (Confalonieri, Salton, & Fabiano, 2017).
Cardiovascular system. In sepsis, involvement of the cardiovascular system
pertains to the heart and systemic circulation. Manifestations of cardiovascular
involvement can include left ventricular strain and elevated troponin in the absence of
any sign or symptom of acute coronary vascular blockage. Damage at the cellular level is
believed to be the result of hypoperfusion (inadequate delivery of oxygen to the tissues),
resulting in decreased functional capacity of the myocardial tissue. In some instances,
inotropic drugs such as Dobutamine can help with cardiac output. Cardiovascular system
involvement is generally evaluated by measurement of mean arterial pressure (MAP). A
MAP < 70mmhg is the threshold for consideration of shock (Levy, 2003). Shock can be
triggered in sepsis by capillary leak from low serum albumin from nutritional
malabsorption and other causes. Management of cardiovascular compromise can include
IV administration of albumin and nutritional support (Bossier et al., 2017).

7
Central nervous system. In sepsis, involvement of the nervous system pertains to
cerebral function due to hypoperfusion, sepsis related encephalopathy or toxic
encephalopathy from sedating medications. Manifestations of nervous system
involvement could be an altered level of consciousness (assessed by Glasgow Coma
Scale) and delirium (assessed by the Confusion Assessment Method [CAM]) or CAMICU. Delirium, also known as acute confusion, is a sudden change in alertness from
baseline with or a waxing and waning in alertness. Management for delirium in a patient
that has sepsis would depend on severity and might include treatment of underlying
infection, removal of Foley catheter, discontinuation of benzodiazepine medications, or
reduction in any use of restraints (icudelirium.org).
Digestive system. In sepsis, digestive system involvement pertains to the liver
and the digestive tract. Manifestations of liver involvement can include acute elevation
of liver enzymes, known as “shock liver.” The digestive system can be affected in sepsis
by decreased ability to absorb nutrients, as well as increased risk of gastric bleeding and
perforation (believed to be a result of hypoperfusion). Management is aimed at fluid
resuscitation to ensure adequate perfusion of tissues with fluids and nutrients (Gazmuri et
al., 2017).
Genitourinary system. In sepsis, genitourinary system involvement pertains to
the kidneys with acute kidney injury (AKI) resulting from pre-renal azotemia or
hypoperfusion of the kidney. Manifestations include an increase in elevated serum
creatinine (in the absence of pre-existing renal disease) and diminishing urine output. A
delicate balance of fluid resuscitation, in addition to the administration of loop diuretics
to draw fluid into the distal tubules, can help to reverse AKI. Caution must be used as
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there is risk of fluid volume overload with fluid resuscitation versus fluid volume
depletion with the use of loop diuretics (Bellomo et al., 2017).
Clinical Indicators of Sepsis
Increasing attention is being paid to at-risk patients for a variety of high cost, high
mortality conditions and syndromes. Sepsis is one of the “of concern” syndromes causing
healthcare organizations to implement surveillance systems. For patients in critical care
settings, a variety of indicators include vital signs, urinary output, and hemodynamic
pressures. Two critically important indicators include serum lactate and the Sequential
Organ Failure Assessment (SOFA) score.
Serum lactate. Lactate is an important consideration in the critically ill patient
with sepsis. Along with other signs of vital organ damage, an elevated serum lactate is
one of the cardinal signs of tissue damage in a patient with sepsis. Therefore, an elevated
serum lactate is often used by clinicians when determining a differential diagnosis of
sepsis (Ganesh, Sharma Varghese, & Pillai, 2016).
Lactate is a by-product of anaerobic metabolism. In sepsis, cells are thought to
resort to anaerobic metabolism due to hypoperfusion of tissues, resulting in disrupted
oxygen delivery to the tissues. Oxygen is metabolized within the cell by powerhouse
organelles called the mitochondria. A four-step process along the electron transport chain
within the mitochondria reduces oxygen to Adenosine Tri Phosphate (ATP) or usable
energy. When cells are deprived of oxygen, they convert to anaerobic metabolism,
breaking down protein into much smaller yields of ATP, releasing lactic acid or lactate
into the serum. As serum lactate is an acid, this process acidifies the blood, lowering the
pH, and contributing to a state of metabolic acidosis.
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SOFA score. The SOFA score has been validated as a predictor of patient acuity
and mortality risk (Raith et al., 2017). In sepsis, it is used as a proxy identifier for sepsis,
as it can predict mortality risk. For example, a patient with a SOFA score of 7-9 has a
mortality risk matching that of sepsis; and in the presence of infection, matching
mortality risk to presence of infection is the most specific way to identify severe sepsis
and sepsis shock given the state of the science (Raith et al., 2017). As the score
increases, mortality risk increases. For example, score of 0 represents risk of mortality of
<10% and an extreme score of 24 would represent 100% mortality. As there is no gold
standard diagnostic test or indicator for sepsis, the SOFA score is used in clinical
decision-making to determine if a patient has sepsis when there is a suspected infection.
SOFA scores have been recently tested for specificity over SIRS and qSOFA (modified
SOFA with only three criteria), demonstrating improved specificity for prediction of
mortality over SIRS (p< 0.001) and qSOFA (p<0.001) with validity of Area Under
Receiver Operating Curve (AUROC) 0.753, 99% CI (0.750-0.757). Reliability statistics
are not reported.
Sepsis Treatment and Management
In 2001, management of sepsis gained world attention. The algorithmic, goaldirected recommendations from a randomized control trial were accepted as the gold
standard for treatment by the SCCM and the SCC was born (Rivers et al., 2001). The
recommendations were protocolized management aimed at targeted therapy for fluid
resuscitation, blood pressure support, and oxygen delivery. Years later, the Rivers et al.
study would be criticized for its lack of generalizability, as it was done at a single
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medical center. An additional criticism was that the study’s outcomes were not compared
to outcomes associated with usual/reasonable care (Cho, 2005).
In 2014, a large scale 31-center randomized trial challenging the protocolized care
was published in the New England Journal of Medicine (Angus et al., 2014). As a result,
the SSC then adopted goal directed care, giving providers the freedom to use their best
clinical judgment in managing sepsis, provided they were guided by evidence-based
targets for mean arterial blood pressure, serum lactate, and time to antibiotics. Recent
studies now recommend delivery of antibiotics within one hour of identification of sepsis
because it is associated with improved survival (Wallgren, Antonsson, Castren, &
Kurland, 2016).
Septic Shock
When the initial sepsis is not managed early in its course, septic shock may be the
next critical stage. In septic shock, the patient’s circulatory system can no longer be
maintained and treatment involves managing the mean arterial pressure (MAP) using
vasopressors to maintain a value >65mmhg. Patients who reach this level of clinical
deterioration meet the criteria for a diagnosis of septic shock (Lee & An, 2016). The
insult to the circulatory system is the result of poor vascular tone or of capillary leakage
from decreased absorption of albumin. This cascade results in hypoperfusion.
Hypoperfusion is the cornerstone of shock, requiring resuscitation that is directed to
restore of functionality of the tissue (Marik, 2010). As part of the resuscitation efforts,
current guidelines recommend that patients who are unable to maintain a mean arterial
pressure of 65-70mmhg require vasopressors to maintain blood pressure to support tissue
perfusion (Dellinger et al., 2013).
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Sepsis and the Patient in the ICU
Patients with sepsis who are admitted to the ICU have multisystem problems
requiring intensive nursing surveillance and supportive care as well as management from
an interdisciplinary team. When sepsis involves organ dysfunction and multiple systems
are affected, the patient has progressed to severe sepsis (Angus & Van der Poll, 2013).
These patients need organ support for any system involved. Patients need intubation and
ventilation for respiratory failure, dialysis for renal failure, screening for and mitigation
of delirium, IV bolus fluid resuscitation to address overall failure of other systems
(hepatic, gastrointestinal, integumentary) due to hypoperfusion and inotropic infusions
for cardiac failure (Angus & Van der Poll, 2013).
When patients are unable to maintain a mean arterial pressure despite fluid
volume resuscitation of 30ml/kg of a crystalloid such as normal saline, sepsis has evolved
to septic shock and patients require IV vasopressor support (Dellinger et al., 2013). In
addition to antibiotic therapy, sepsis patients in the ICU require prophylaxis because they
are vulnerable to secondary infection. Additional intensive treatment is frequently needed
for thrombosis (deep vein, pulmonary, cerebral), gastrointestinal bleeding, neuromuscular
deconditioning and pressure ulcers. Prophylaxis includes tube feeding, anticoagulation
therapy and peptic ulcer prophylaxis, physical therapy, and interventions aimed at
preventing skin breakdown (e.g., frequent turns, prophylactic dressings, off-loading of
pressure areas and bony prominences, perineal care) (Dellinger et al., 2013; Pather &
Hines, 2016).
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Oxygen Consumption in the ICU Patient with Sepsis
Oxygen consumption in the ICU patient with sepsis is a novel concept that has not
been adopted clinically. As mentioned in the introduction, oxygen consumption in sepsis
has not been sufficiently studied in vivo (Kreymann et al., 1993). Oxygen consumption as
measured for other purposes includes evaluation of metabolic need and cardiac output.
Indirect Calorimetry
Oxygen consumption is the clinical measure of aerobic respiration (Kreymann et
al., 1993). Oxygen consumption can be measured clinically by way of indirect
calorimetry. Indirect calorimetry measures the percentage of oxygen inspired versus the
percentage of carbon dioxide that is expired. This value is then entered in to an equation
to determine energy expenditure (Marson, 2004). Traditionally, these measures have been
captured in hospitalized patients to determine metabolic demand for prescribing tube
feeding (Urden et al., 2014).
Cardiac Output (Fick Principle)
In a steady state, oxygen coming in from the lungs should equal oxygen in the
pulmonary vein (v02), which should also equal oxygen consumed (V02) during normal
(aerobic) cellular respiration. Measured levels of arterial 02 (a02) and mixed venous 02
can be inputted into the following equation to determine cardiac output: CO = V02 (a02v02). These measurements are obtained by way of a Swanz-Ganz pulmonary arterial
catheter (Rhoades & Bell, 2009).
Oxygen Consumption – Lactate Connection
Serum lactate accumulates during hypoperfusion of tissues. Fluid resuscitation
and adequate delivery of oxygen should encourage normal aerobic metabolism and the
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elimination of lactate from the serum. However, in sepsis, lactate remains despite fluid
resuscitation and often continues to rise (Lee & An, 2016). It is for this reason that
elevated serum lactate serves as a differentiator for septic shock over other forms of
shock.
Referring to the physiological model of the Electron Transport Chain (see
Theoretical Underpinnings below), when cells cannot consume oxygen to produce ATP,
protein is used, resulting in the accumulation of the byproduct of anaerobic respiration,
lactic acid. Therefore, elevated serum lactate serves as a distal proxy measure of impaired
oxygen consumption.
Serum lactate should be considered every time a patient triggers an alert for
sepsis. Serum lactate should be re-evaluated within 6 hours of initiation of any treatment
provided for sepsis (Levy et al, 2003). However, it should be reinforced that serum
lactate, while considered a differentiator in sepsis, is a distal proxy measure for impaired
oxygen consumption.
Problem Statement
Any type of shock has the potential to result in hypoperfusion. However,
somehow, elevated serum lactate, despite adequate fluid volume resuscitation and oxygen
delivery, cannot be overcome and therefore, remains a differentiator for all forms of
sepsis.
Why then, despite availability of oxygen in the resuscitated septic patient, do cells
continue to contribute lactate from anaerobic respiration into the serum? Could it be a
dysregulation in the cells’ ability to metabolize or consume oxygen in the case of sepsis?
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There is no gold standard for a diagnosis of sepsis. The determination of sepsis is
a clinical decision left to the discretion of the interdisciplinary clinical team members,
including ICU nurse clinicians. Therefore, more evidence, especially evidence that could
serve as a potential specific biomarker for sepsis to ICU nurses, is needed to assist these
clinicians. Evidence of cellular dysregulation in the form of oxygen consumption data
may yield a much-needed added specific and sensitive indicator for sepsis.
Study Purpose and Aims
The purpose of this study was to investigate the relationships between select available
demographics, resting energy expenditure (REE), serum lactate, SOFA score mortality index,
oxygen consumption (by way of measuring V02 and VC02), and sepsis.

Specific Aims
This study had four specific aims:
Aim #1: Describe patient demographics, serum lactate, SOFA score mortality
index, sepsis diagnosis, and 02 consumption.
Aim #2: Describe the difference in oxygen consumption in ICU patients with and
without a diagnosis of sepsis.
Aim #3a: Describe the relationships between gender, age, REE, height, weight,
lactate, and VO2.
Aim #3b: Describe the relationships between gender, age, REE, height, weight,
lactate, and VCO2.
Aim #4: Describe the relationships between age, gender, height, weight, VO2,
VCO2, lactate, SOFA, REE, and sepsis
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Theoretical Underpinnings
The conceptual framework for the study is derived from theories in the field of
quantum mechanics in the context of normal human cell physiology (Huether and
McCance, 2015; Van Ness, 1969). Quantum mechanics explains a thermodynamic
system, a system where energy can change states within a system. The electron transport
chain is an in vivo model of a thermodynamic system.
Quantum Mechanical Model: Second Law of Thermodynamics
From the discipline of physics, the quantum mechanical model is applying
mathematical principles to subatomic particles to explain energy and momentum (Ismael,
2015). Within the quantum mechanical model, the second law of thermodynamics is
described. The second law of thermodynamics concerns transfer of energy within a
system, for example, an engine (Van Ness, 1969, p52). In an engine, heat is applied to a
fuel source, creating a force that drives movement forward. Mitochondria, within the
cell, are another example of a thermodynamic system. Energy is not lost within the
boundary of the mitochondria, it is only converted to useable energy in the form of ATP.
Normal Human Cell Physiology: The Electron Transport Chain
Normal aerobic cellular metabolism, needed to sustain life, yields energy in the
form of ATP from reduction of oxygen along the electron transport chain within the
mitochondria (Rhoades & Bell, 2009, p320). Reduction of oxygen occurs along four
points within the electron transport chain, with diminishing energy potential over time
toward inertia, or in this case, natural death of the cell. The model of the electron
transport chain is thermodynamics in vivo (Laisk & Walker, 1989), where fuel (oxygen)
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is converted to energy to drive cellular processes. Figure 1 demonstrates the down
regulation of energy potential over time, in normal human aerobic cellular metabolism.

Figure 1. The Electron Transport Chain

The overall purpose of many pharmaceuticals is to interfere with damaged processes
along the electronic transport chain caused by genetic mutations, diseases and injuries.
Study Research Conceptual Framework
The study research conceptual framework demonstrates the relationship between
the independent variables and having a clinical diagnosis of sepsis.
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Serum Lactate

Oxygen
Consumption
Sepsis

Demographics
Energy
Expenditure

SOFA Score
Figure 2. Conceptual Framework

Serum Lactate and Sepsis
Measurement of serum lactate, as a marker for hypoperfusion in sepsis, has been
driving sepsis identification since Emmanuel Rivers first recommended Early Goal
Directed Therapy (EGDT) in 2001 (Rivers et al., 2001). Per the International Sepsis
Definition Conference of 2001, serum lactate of >3.0 mmol/L is indicative of
hypoperfusion in sepsis (Levy et al, 2003). Since the launch of EGDT, the sepsis
management apparatus had hinged on the notion that elevated serum lactate in sepsis is
due to hypoperfusion, or impaired delivery of oxygen (Rivers et al., 2001).
Around the same time that EGDT was published, an alternative hypothesis was
recommended by Dr. Mitchell Fink; that elevated serum lactate, as well as elevated
venous oxygen, was in fact, due to mitochondrial dysfunction rather than impaired
delivery of oxygen (Fink, 2001). Fink coined the term cytopathic hypoxia to describe the
notion of mitochondrial dysfunction in sepsis. Fink forewarned implicitly that ignoring
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cytopathic hypoxia, and only subscribing to hypoperfusion as an explanation for elevated
lactate, was a dangerous path to take. However, his recommendation never gained any
traction, and EGDT remained the gold standard for sepsis care (Dellinger et al., 2012).
Dr. Fink was part of the University of Pittsburgh team who published in 2014 that EGDT
had no benefit over usual care (Angus et al,, 2014). Unfortunately, Dr Fink died in 2015
and was unable to investigate oxygen cytopathic hypoxia as it might be related to sepsis.
Oxygen Consumption and Sepsis
As mentioned above, elevated serum lactate can represent impaired delivery of
oxygen. However, it can also represent impaired intracellular consumption of oxygen. As
a result of a shift to anaerobic metabolism, elevated serum lactate can occur due to
unavailability of oxygen or due to the inability to convert available oxygen into useful
energy. A study published in 1993 demonstrated clinically significant (p< 0.001)
differences in oxygen consumption were observed between mechanically ventilated
patients with sepsis, sepsis syndrome, septic shock, and healthy adults (Kreymann et al.,
1993). In this study, oxygen consumption was compromised in the sepsis syndrome and
in septic shock patients compared to the healthy adults (metabolic norms) (p<0.001).
Study weaknesses included 1) no validity or reliability statistics reported for the
instruments; 2) the monitor used was simply described as a “pragmatic oxygen sensor
and infrared C02 sensor”; and 3) definitions and stratifications of sepsis have changed
since 1993, making it extremely difficult to apply this evidence today. Because there is
limited research investigating the relationship between oxygen consumption and sepsis, it
is important to add to this limited body of knowledge.
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Energy Expenditure and Sepsis
Energy expenditure (REE), or resting metabolic rate, is calculated from oxygen
consumption (V02) and carbon dioxide production (VC02) in aerobic respiration. The
Weir equation is used to determine metabolic need. This is called indirect calorimetry and
is usually calculated to determine the rate of tube feeding required for the critically ill
(Urden et al., 2014). The Weir equation is as follows: EE kcal/day = 3.941 x V02(L/min)
+ 1.11 x VC02(L/min) x 1440 (Stapel et al., 2015).
Since calculation of REE is dependent on measures of oxygen consumption, a
difference in oxygen consumption will therefore influence a difference in REE. Thus, if a
significant difference in oxygen consumption exists in a patient with sepsis compared to a
patient without sepsis, a significant difference in REE would exist in that patient with
sepsis compared to a patient without sepsis. Thus, REE may be an important variable in
determining the odds of a patient having sepsis.
SOFA Score and Sepsis
In 2002, a manuscript was published comparing the Acute Physiology and
Chronic Health Evaluation (APACHE II) score against the Multiple Organ Dysfunction
Score (MODS) and the Sequential Organ Failure Assessment (SOFA) score for
prediction of mortality in critical illness (Bota, Melot, Ferreira, Ba, & Vincent, 2002).
No significant difference in the performance of the measures in predicting sepsis
was found for patients who did not present with shock compared to patients who did
present with shock. For patients who did present with shock, SOFA was found to be most
predictive of mortality over APACHE II and MODS. The AUROC for the SOFA of
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0.750 was significantly different compared to MODS of 0.694 (between means difference
p<0.01). The AUROC for APACHE II was not reported.
When the new definition of sepsis was published in 2016, the consensus
recommendation for improved sepsis identification was to use the SOFA score to identify
patients at risk for sepsis (Singer et al., 2016). Investigators conducting a retrospective
analysis using the University of Pittsburgh dataset for patients with suspected infection
determined that the AUROC for SOFA in predicting mortality was 0.74 compared to the
SIRS of 0.64, within a between means difference of p<0.001. This group stated that the
traditional focus on inflammation and the SIRS response was “misleading” and lacked
specificity for sepsis. SOFA was recommended for improved specificity, specifically in
ICU patients.
Most recently, findings from a large-scale study (184,875 patients at 182 ICUs
across New Zealand and Australia) substantiated the use of the SOFA score to predict
mortality in patients with suspected infection who are admitted to the ICU (Raith et al.,
2017). This study was also a retrospective database analysis. The AUROC for SOFA at
0.753 was significantly different when compared to the SIRS AUROC (0.589) with a
between means difference of p<0.001.
Without a gold standard to identify sepsis, clinicians remain dependent on the
SOFA mortality index scores for identification of patients at risk for sepsis. A patient
with a SOFA score of 8 (20%) to 12 (50%) has a mortality index matching that of a
diagnosis of sepsis (Raith et al., 2017). Pertaining to the examples above, SOFA has been
repeatedly demonstrated to have superior specificity for predicting mortality over the
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APACHE II and MODS. Based on this evidence it will be important to measure the
relationship between the SOFA score and sepsis.
Summary
This chapter has introduced the condition of sepsis with background pertaining to
the pathophysiology and history of sepsis management. A case for the study has been
presented. Chapter 2 will offer a systematic review of the literature to investigate what is
currently known about oxygen consumption in sepsis.
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CHAPTER TWO
Systematic Review
In the 25 years since the original “SEP-1” definition of sepsis in 1992, many
patients have died, many lives have been significantly altered, and many resources have
been spent while the mortality from sepsis continues to rise. The cost to patients and
families in terms of loss and disability are immeasurable. In addition, there is an
environmental cost to consider. The downstream effects of decades of empiric, broad
spectrum antibiotic use include increasing rates of bacterial resistance and alterations to
the human microbiome. Costs to healthcare resources are also considerable. Under the
Value Based Purchasing plan, the Centers for Medicare & Medicaid Services (CMS)
have enlisted the Hospital Engagement Networks to assist with monitoring of patient
safety indicators. The Agency for Healthcare Research & Quality (AHRQ) reports on
healthcare delivery costs captured by the Healthcare Cost and Utilization Project
(HCUP). Their 2014 report, (HCUP brief #185), described the average cost of treating
sepsis in hospital in 2011 as $45,500 per case, with a total number of cases at 304,367.
That is a cost of $1.5 billion annually on sepsis care (Barrett, Smith, Elixhauser,
Honigman, & Pines, 2014).
In October of 2015, CMS launched a campaign to optimize the current state of
sepsis care in the United States. As the entity entrusted to monitor quality and ensure
patient safety with a goal of reducing mortality, CMS will eventually mandate hospitals
to report the incidence of sepsis, as well as measures for sepsis management. Mandatory
reporting would apply to all individuals who rule in for sepsis based on inclusion criteria
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endorsed by the Surviving Sepsis Campaign; patients must have two or more of the
following signs in the presence of confirmed or suspected infection:
Temperature >38C or <36C
Heart Rate >90bpm
Respiratory Rate >20/min
White Blood Cell Count >12,000/ml or <4,000/ml or >10% immature bands
Reporting was expected to be mandatory by fiscal year 2018, however that target
date has been delayed and remains to be determined. Many hospitals are finding these
inclusion criteria, based on the Systemic Inflammatory Response Syndrome (SIRS)
model, overly sensitive in identifying patients (Graham, Krall, Presente, Saucier, &
Butler, 2016). As the SIRS model is an adaptive model, these criteria can be present in
adaptive states, such as multiple forms of stress, anxiety, pain, or milder illness.
In February 2016, a new definition of sepsis, “SEP-3,” was introduced. This new
definition described sepsis for the first time as a “dysregulated” host response to infection
(Singer et al., 2016). The nature of the dysregulated response is yet to be declared.
Understanding the dysregulated nature of sepsis offers an opportunity to yield criteria for
identification that have increased specificity for sepsis over SIRS.
Mitochondrial Dysfunction in Sepsis
Mitochondrial dysfunction in sepsis has been tested in the laboratory setting;
however, its role in sepsis is still unclear. The discovery of a clear relationship between
mitochondrial dysfunction and sepsis could potentially provide new information to
inform the new definition of sepsis as a dysregulated response. For the purposes of this
paper, mitochondrial dysfunction is operationalized as dysregulation of oxygen
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consumption along the electron transport chain. Mitochondrial dysfunction has been
studied in human cells at the level of laboratory science and is now being tested in animal
studies. No clinical evidence exists in the literature to demonstrate what mitochondrial
dysfunction in sepsis would look like as a clinical, in vivo manifestation of the disease.
The purpose of this paper is to examine the existing scientific evidence regarding the
relationship between mitochondrial dysfunction and sepsis.
Entropy and Aerobic Respiration
Mitochondria are intracellular organelles responsible for aerobic metabolism or
the production of energy in the form of adenosine triphosphate (ATP). The mitochondria
are a thermodynamic system and thus subjected to the second law of thermodynamics.
The second law of thermodynamics states that the irreversible natural degradation of
matter occurs over time. This concept is referred to as entropy (Van Ness, 1969).
Mitochondria are exquisitely designed to create useable energy within the boundary of its
system. Energy is not lost in the process, but it is transformed within the system. The
mitochondrial system is considered an open system, as it can exchange matter and energy
across its boundaries. Thus, mitochondria are subject to entropy (disorder and
dysfunction over time) as the system proceeds through its lifespan toward an irreversible,
natural death.
Sepsis Management
Although strides have been made since sepsis was first defined in 1992 as the
SIRS response to infection, sepsis remains a leading cause of death with a mortality rate
of 30% (Bone et al., 1992; Vincent, Martin, & Levy, 2016). Goals of sepsis management
include aggressive fluid resuscitation, adequate oxygenation, and early empiric antibiotic
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therapy (Seymour & Rosengart, 2015). Treatment recommendations have not changed
significantly since 2001 when the Surviving Sepsis Campaign (SSC) championed Early
Goal Directed Therapy (Rivers et al., 2001). These recommendations were tested by a
National Institute of Health (NIH) funded study which challenged the recommendations
and published no difference in outcomes when measured against usual care (Angus et al.,
2014). However, one could argue that “usual care” has regressed to mean targets that the
SSC has championed and endorsed.
Cytopathic Hypoxia and the Electron Transport Chain
The electron transport chain within the mitochondria creates useable energy for
the organism in the form of ATP in normal, aerobic cellular respiration. The process of
ATP synthesis consists of four complexes. Each complex represents an area for necessary
sequential enzymatic cytochrome oxidase activity. Potential for disruption of these
normal enzymatic processes occurs when nitric oxide (NO) reacts with ROS creating
peroxynitrite (ONOO-), leading to further downregulation of normal mitochondrial
respiration. This disruption leads to conversion to anaerobic respiration, resulting in
accumulation of excess serum lactate in the septic host.
The phenomenon of mitochondrial dysfunction in sepsis was first coined by Dr.
Mitchell Fink in 2002, as a process he named “cytopathic hypoxia” (Fink, 2002). Fink’s
description of cytopathic hypoxia is a process in which enzymatic reactions along the
electron transport chain are disrupted in the presence of nitrous oxide (NO). NO is a
substrate produced when cells are exposed in vitro to lipopolysaccharide endotoxin
(LPS), a laboratory proxy for bacterial infection. This early process is a reversible
(capable of recovery). If further disruption of normal respiration occurs, NO devolves
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into ONOO- yields when NO comingles with the reactive oxygen species (ROS),
superoxide (02-). Once ONOO- production occurs, disruption is irreversible (incapable
of recovery). As 02- is generated by NO disruption of enzymatic processes along the
electron transport chain, it is only a matter of time before ONOO- is produced and
mitochondrial dysfunction becomes irreversible (entropic), resulting in cell death.
Materials and Methods
Healthcare literature databases were searched for the review using key terms to
elicit relevant literature on mitochondrial dysfunction in sepsis. Articles retrieved were
evaluated for inclusion/exclusion (see Study Selection below). A subsequent search was
done using terminology derived from themes in the retrieved articles.
Key Terms
The initial search was conducted using the terms sepsis, mitochondrial
dysfunction, and cytopathic hypoxia. The initial review of the literature identified
nicotinamide adenine dinucleotide (NAD) as a consistent theme in cytopathic hypoxia.
As NAD is also a key term in Fink’s conceptualization of cytopathic hypoxia, it was
added to the mix of terms for a subsequent search.
Data Sources
Articles were retrieved from databases PubMed and CINAHL (Cumulative Index
of Nursing and Allied Health Literature). The selection process is demonstrated in Table
1.
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Table 1.
Selection of Articles for Review
Database/Search
Engine
CINAHL

CINAHL

Terms Used
Sepsis
Mitochondrial
dysfunction
Sepsis
Cytopathic hypoxia

Number of Articles
Retrieved

Included/Excluded
25
8/17

2
*Both were captured by
previous search*

PubMed

Sepsis
Mitochondrial
dysfunction

PubMed

Sepsis
Cytopathic hypoxia

31

Sepsis
Mitochondrial
dysfunction
Cytopathic hypoxia

19 (of
original 576)

4/15

Sepsis
Mitochondrial
dysfunction,
Nicotinamide adenine
dinucleotide

22 (of
original 576)

4/18

PubMed

PubMed

576

1/1
Deferred, add
Cytopathic hypoxia,
add nicotinamide,
add adenine
dinucleotide
6/25

Study Selection
Studies of human subjects or human cells, after 2001, full text, available in
English from peer reviewed journals, original experimental, quasi experimental, or cohort
studies only. Studies examining the relationship between mitochondrial dysfunction in
sepsis, using a combination of keywords to serve as search terms (sepsis + mitochondrial
dysfunction, sepsis + cytopathic hypoxia, sepsis + mitochondrial dysfunction +
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cytopathic hypoxia, sepsis + mitochondrial dysfunction + NAD). After deselecting for
duplicates, animal studies, non-English text, editorials, reviews of the literature, and those
predating 2001, of the 99 articles retrieved, only 10 were selected to meet criteria for
study selection.
Data Extraction and Risk of Bias Assessment
Searches were done solely by the author to eliminate risks to inter-rater reliability.
Some variability in instrumentation exists between the studies included in the analysis
and where consistent instrumentation may have been used in more than one study,
measurements were independent of each other.
Techniques for culture and inoculation of cells of subjects demonstrate
consistency as cells were either from individuals with a diagnosis of sepsis, or cells
inoculated with lipopolysaccharide (LPS) gram-negative endotoxin.
Description of Included Studies
Characteristics of the included studies are listed in Table 2. All studies were
conducted on human cells. Four studies used cells from human patients infected with
sepsis or septic shock (platelets, peripheral blood mononuclear cells, skeletal muscle
cells, plasma). Six studies were conducted on commercially available human cells
(endothelial cells, hepatoma cells, human dermal fibroblasts, renal tube epithelial cells,
umbilical vein endothelial cells, colon carcinoma cells). Six studies were laboratory
experimental, two were prospective observational, one cohort, one quasi-experimental.
Of the laboratory studies, four used a lipopolysaccharide endotoxin as a proxy for sepsis,
one used cytomix (a commercially available mixture of cytokines), and one used serum
from sepsis patients to inoculate commercially available cells. Three studies included
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pharmacologic intervention to investigate reversibility of mitochondrial dysfunction in
sepsis.
Table 2.
Articles Included in Review
Study

Country

Setting

Study Design

Study
Population
Platelets isolated
from patients
with septic
shock,
cardiogenic
shock, and
controls

Instrumentation

Findings

Lumi-aggregometry
Spectro-photometry

Depressed
responsiveness
of platelets
and
respiratory
chain activity
cases (r sq.
0.36, 0.38,
0.43 for the 3
respective
complexes
measured
Mitochondrial
activity
significantly
impaired
compared to
control, with
an increasing
prevalence in
organ failure
(r=0.46,
p<0.005).
Pharmacologic
activation of
PGC1a and
NFE2L2
pathways
protected loss
of
mitochondrial
membrane
potential and
activity
(p<0.0002,
p<0.00009
and p<0.5 and
p<0.0001)
respectively
Mitochondrial
oxygen
consumption
altered by 1622% (p<0.05),
enzymatic
markers (ci
Ciii) altered
by 32% and
42% (p<0.05).

Protti et al.
(2015).

Italy

Hospital

Prospective,
observational,
case control
study

Japiassu et
al. (2011).

Brazil

Hospital

Cohort Study

Peripheral blood
mononuclear
cells, isolated
from 20 patients
with septic
shock, 18
uncomplicated
post op hips as
control

High resolution
respirometry

McCreath
et al.
(2016).

UK

Laboratory

Experimental

Commercially
available
Human
endothelial cells,
control &
treatment

Fluorimetry,
spectrophotometry

Garrabou et
al.
(2012).

Spain

Hospital

Quasiexperimental

19 patients with
a diagnosis of
sepsis, 20
matched
controls from
post op hip
surgery.

Western blot assay,
polarography,
spectrophotometry,
flow cytometry,
Luminex assay
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Jeger et al.
(2015).

Switzerland

Laboratory

Experimental

commercially
available
hepatoma cells
(HepG2) and
primary
hepatocytes. 2
groups:
intervention &
matched control

High resolution
respirometry

Trentadue,
R. et al.
(2012).

Italy

Laboratory

Experimental

commercially
available
Normal Human
Dermal
Fibroblasts
(NHDF-neo).

Oxygen
polarography,
Milliplex Map assay

Quoilin, C.
et al.
(2014).

Belgium,
France

Laboratory

Experimental

commercially
available human
renal tube
epithelial cells
(HK-2)

Multiple commercial
assays, laboratory
reduction
procedures,
fluorometry, Flow
cytometry

Lorente, L.,
et al.
(2011)

Spain

Hospital
ICUs

Prospective,
multi center,
observational

96 septic
patients from 6
intensive care
units (ICU) in
Spain

Spectrophotometry,
calorimetry

sepsis severity
correlated
with depressed
mitochondrial
activity (r
squared 0.715)
Decrease in
respiration
(p<0.006 &
0.007) for
HepG2 at 24h
respiration
observed to
decrease at 8h
(p<0.016).
Mitochondrial
membrane
potential and
ATP content
decreased in
compared to
control
(p<0.0001)
Depressed
respiration vs.
control (p<
0.0001),
depressed
mitochondrial
enzymatic
activity (p<
0.001 & p<
0.01). H2O2
generation
increased (p<
0.0001) over
control.
NO increased
(p<0.0001)
NOX-4
increased
(p<0.008),
cytochrome c
was elevated
at 6h & 24h
(p<0.05,
p<0.08).
complex 4
activity
dropped off in
the LPS group
(p<0.0001).
ATP levels
dropped 30%
at6h z7 24h
(p<0.004,
p<0.0007)
Higher levels
of cytochrome
c was
associated
with long term
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survival at 6
months
(p<0.006).
cytochrome c
activity and
predicted
survival
(p<0.04,
p<0.02). The
ROC for
survival at 6
months was
62% (CI 95%,
0.51-0.74).
For
cytochrome c
activity was
67% (CI 95%,
0.56-0.76,
p<0.003).

Apostolova
et al.
(2011).

Spain

Laboratory

Experimental

Human
umbilical vein
endothethelial
cells (HUVEC),
treatment and
control

Fluorimetry,
Electrode (capturing
P02 pressure drop),
spectrophotometry,
Western Blot
Assay

Khan,
A.U., et al.
(2002).

USA

Laboratory

Experimental

Commercially
available human
colon carcinoma
line cultured
Caco-2 cells.

Multiple commercial
assays and
laboratory reduction
procedures, fiber
optic 02 sensor, and
polarography.

NO and
ONOOincreased
more in the 02
21% group
(p<0.05).
coincubation
with
antioxidant
reduced NO
and ONOOby 75%.
Oxygen
consumption
decreased
(p<0.05), with
a subsequent
increase in
lactate
production
(p<0.037)
over control

Common Instrumentation Used
Instruments used for measurement of substrates include spectrophotometry (three
studies), high resolution respirometry (three studies), polarography (three studies),
fluorimetry (three studies), Western blot assay (two studies), flow cytometry (two
studies). Additionally, multiple other assays were used to identify substrates along the
electron transport chain, mitochondrial membrane potential, and the presence of ATP.

32

Analysis
Studies were evaluated to identify themes for analysis. Many differing
instruments were used in the studies, and a high degree of variability exists between the
substrates measured within the 10 studies included in the review. This illustrates a gap in
the current literature for consistency in measurement.
Table 3 demonstrates the most frequently used instruments identified in the
review, grouped against the most frequently observed substrates. Elements of
mitochondrial function including electron transport chain activity, ATP yield, and
mitochondrial membrane potential were measured as common themes within the studies
reviewed. Fluorimetry, Polarography, & Spectrophotometry yielded the most frequent
observations. Table 2 demonstrates p values of substrates measured (see Findings, Table
2). Of the substrates observed along the electron transport chain, 19 significant p-values
were identified for substrates of respiratory chain activity measured by
spectrophotometry. The substrates measured included cytochrome c oxidase, NADHdehydrogenase, ATP hydrolase, & hydrogen peroxide. The matrix demonstrated the most
frequent distribution of significant findings in respiratory chain activity.
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Table 3.
Grouped p values (p<0.05) of substrates measured

Results
These p-values were then entered in to Statistical Package for the Social Sciences
(SPSS) software for descriptive modeling. P-values for respiratory chain activity of cells
cultured in either sepsis serum of LPS endotoxin versus control were not normally
distributed, rejecting the null hypothesis and therefore, offering evidence of
mitochondrial dysfunction in sepsis consistently among the test cases.
Discussion
Time is Toxin. The articles reviewed in this investigation map out a complex
picture of mitochondrial disruption in the presence of sepsis, especially in the context of a
gram negative LPS endotoxin. The disruption is dynamic, stimulating the production of
reactive nitrogen species (RNS) in the form of nitric oxide (NO), causing eventual,
irreversible disruption of multiple complexes along the electron transport chain by
inhibiting cytochrome oxidase, resulting in decreased ATP synthesis. However, an earlier
study conducted by Borutaite and Brown (1996) demonstrated that irreversibility
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(eventual production of ONOO-) only occurs when high levels of NO are generated, and
reversibility is possible if the process is interrupted before NO rises above a submolecular threshold. Current therapies aimed at fluid resuscitation and oxygen delivery
have not demonstrated to have any capacity to halt or reverse this process. As the cascade
is triggered by the infecting sepsis-causing agent, the bleak analogy of an accelerated
process of entropy in the presence of an LPS endotoxin underscores the urgency of early
antibiotic intervention, that is, if there is any hope of reversibility of inhibition of
cytochrome oxidase.
Time is toxin, and time to antibiotics, should be given the same urgency as “time
is muscle” or “time is brain,” the colloquialisms used to encourage fibrinolytic therapy
for an acute stroke, or percutaneous intervention for acute myocardial infarction. A study
by Wallgren et al. (2016) investigated mortality associated with antibiotic delay in 61
patients presenting to the Emergency Department with overt sepsis versus covert sepsis.
Their findings demonstrated mortality risk associated with time delay to antibiotics.
Delays beyond the first hour dropped survival to 20%. The 2016 SSC consensus
guidelines recommended administration of antibiotic therapy within one hour after
identification of sepsis or septic shock (Rhodes et al., 2017). This was given a “strong
recommendation, moderate quality of evidence” under the Grading of Recommendations
Assessment, Development, and Evaluation (GRADE) system, suggesting that the highest
quality of evidence existed to correlate antibiotics within one hour to survival.
Conclusion
The articles included in the review demonstrated consistent, statistically
significant differences when investigating mitochondrial function in sepsis. The evidence
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however remains weak as there is no consistent thread of instrumentation and measured
substrate within the base of evidence. As the pooled results for spectrophotometry
suggests rejecting the null hypothesis, further investigation is warranted. As the current
state of this evidence is limited to laboratory investigation, it remains to be tested in vivo
to determine clinical significance for mitochondrial dysfunction as a manifestation of
disease in sepsis. In the meantime, our best weapon against sepsis is to protect host cells
with timely administration of antibiotics, as time is toxin.
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CHAPTER THREE
Study Methods
Study Design
This investigation was a retrospective database descriptive study and utilized a
hospital evidence-based practice (EBP) project database and an electronic health record
(EHR) database. The primary dataset was previously developed for the purpose of
collecting metabolic data under an evidenced-based practice model. The original clinical
data had been collected comprehensively at discrete patient encounters, once per patient
during their stay, for the purpose of determining metabolic need and tube feeling
formula/rate.
Potential Significance of Proposed Study
Improving on the specificity and sensitivity for sepsis identification can only
improve each hospital’s CMS bundle compliance, appropriateness of care, allocation of
resources, and result in the best possible patient outcomes. The addition of oxygen
consumption and possibly other independent variables identified in this study may inform
a growing list of more appropriate criteria used for clinical decision-making in the
identification of sepsis among ICU patients. Addressing this gap has the potential to shift
the course of sepsis management for the first time in 25 years.
Statement of Purpose
The purpose of this study was to investigate the relationships between select available
demographics, resting energy expenditure (REE), serum lactate, SOFA score mortality index,
oxygen consumption (by way of measuring V02 and VC02), and sepsis. The cases for this study
were identified via a metabolic dataset that had been developed for a tube feeding EBP project.
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Study Aims
This study had four specific aims:
Aim #1: Describe patient demographics, serum lactate, SOFA score mortality index,
sepsis diagnosis, and 02 consumption.
Aim #2: Describe the difference in oxygen consumption in ICU patients with and
without a diagnosis of sepsis.
Aim #3a: Describe the relationships between gender, age, REE, height, weight,
lactate, and VO2.
Aim #3b: Describe the relationships between gender, age, REE, height, weight,
lactate and VCO2.
Aim #4: Describe the relationships between age, gender, height, weight, VO2, VCO2,
lactate, SOFA, REE, and sepsis.
Setting
Cases included were from a 12-bed medical ICU within a small community
hospital (<150 beds) in Southern California. The population served by this community
hospital includes many community members from multiple local skilled nursing facilities
that are within close proximity to the hospital. Many patients admitted to this ICU are
elderly and frail and are admitted for exacerbations of chronic illness, influenza,
healthcare associated conditions (pneumonia, urinary tract infection), and sepsis. Per
City-Data.com (2018), the ethnic groups within this community are White 63.3%,
Hispanic 18.3%, Asian 11.6%, Black 1.4%, and American Indian 0.5%. The community
is somewhat affluent with a median income of $105,241, and average home cost of
$617,911.
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Sample
Patients admitted from June to December 2017 were selected as cases. All case
data were extracted from an EBP project database.
Inclusion criteria: All patients included in the original EBP project were included
as cases in this research study. Specifically, these were patients in the ICU intubated for
mechanical ventilation who were anticipated to require tube feeding.
Exclusion criteria: Only cases in the original EBP project were included in this
research study; there were no exclusion criteria for this research study. However, it
should be highlighted that ICU patients who were ventilated but not identified as
requiring tube feeding (e.g., NPO status, comfort care) would not have been in the
original EBP database; therefore, they were not included in this research study.
Study Variable Operational Definitions and Measures
Demographics. Age, weight, and gender were abstracted from the EHR. Age and
weight were included because they each can have an effect upon metabolic demand. Two
options for gender were available: male or female.
Serum Lactate. Serum lactate values are typically used by physicians to
determine a differential diagnosis of sepsis. Serum lactate guides fluid volume
resuscitation and repeat lactate values are used to inform the provider of patient’s
responsiveness to treatment. Serum lactate is also considered a current differentiator for
septic shock over other types of shock. Serum lactate values were abstracted from the
EHR as a continuous numeric value.
Sepsis versus Non-Sepsis. There is no gold standard for the diagnosis of sepsis.
At the hospital site used for this study, diagnosis of sepsis was made clinically at the
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discretion of the physicians. Sepsis diagnosis data were abstracted from the EHR and
options included yes or no.
SOFA Score. The Sepsis-related Organ Failure Assessment (SOFA) is a
mortality index score (range 0-24) and is a calculated number based on six clinical
criteria (Glasgow Coma Scale, Platelets, Mean Arterial Pressure, Serum Creatinine, total
bilirubin, and Partial Pressure of Arterial Oxygen over Fraction of Inspired Oxygen or
P/F ratio). Patient specific values for these criteria are assigned a final score based on the
criteria. The SOFA score has gained acceptance as the most specific metric for sepsis.
The SOFA Index score was calculated by the investigator per standardized
instructions that are based on abstraction of the six clinical criteria from the medical
record and plotted against the “calculator” or value index table (Table 4). A higher score
is interpreted as an increased risk of mortality.
Table 4.
SOFA score mortality risk index criteria

Oxygen Consumption. Oxygen consumption is the conversion of inspired
oxygen (02) to Adenine Tri-Phosphate, or ATP, where carbon dioxide is a by-product of
this reaction. For the EBP project, oxygen consumption was measured using the
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MetaphorTM metabolic monitor by attaching it to the ventilator circuit to evaluate
metabolic demand and was used clinically for the purpose of determining tube feeding
requirements. Oxygen consumption was calculated by analysis of gases on inspiration
against the net gains/losses of gases on expiration. Oxygen consumption data in the form
of VO2 and VCO2 (measures discussed below) were abstracted from an evidence-based
practice project database.
Table 5.
Study Variables
Variable

Operational Definition

Instrumentation/Data
Sources

Measures

Demographics

Age, Gender, Weight

EHR

Age in years, Gender (M/F),
Weight in kg

Lactate

Serum lactate
(lactate dehydrogenase
protein in blood)

Electronic Health Record
(EHR)

Laboratory value for serum lactate
in mmol/L

02 Consumption

Net pp O2 inspired &
net pp C02 expired

Metabolic Monitor

V02 & VCO2 values in mmHg

REE

Resting energy
expenditure

Calculated using EHR
data & Weir Equation

Weir Equation:
Metabolic rate (kcal per day) =
1.44 (3.94 VO2 + 1.11 VCO2)

SOFA Severity
Score

Mortality index (0-24)
based on 6 criteria

Calculated using EHR
data & SOFA Score
Calculator

SOFA Score Calculator: Calculated
based on 6 criteria (assessment and
lab data) at admission and 48 hours

Sepsis Diagnosis

Clinical diagnosis of
sepsis as determined by
MD

EHR

Sepsis (yes/no)
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Instrumentation
While no instrumentation was expressly used to collect data for this study,
instruments were used previously in the clinical setting to obtain the original patient
assessment data for the EBP project.
Metabolic Monitor. The metabolic monitor used for the earlier EBP project was
a MetaphorTM unit developed by TreyMed (Milwaukee, WI). The device is non-invasive
and attaches to the ventilator circuit in a similar way that standard end tidal C02
monitoring devices attach to ventilators. The MetaphorTM unit is easily attached and
removed from a ventilator. No published data exists on reliability for the MetaphorTM.
Oxygen consumption is the gold standard for determination of metabolic need in
the critically ill patient and globally represented as a Respiratory Quotient (RQ). RQ =
VCO2 eliminated/VO2 consumed. Raw scores can range from 1.0-0.7. Raw scores are
acceptable for reporting, provided the measurement device has passed internal calibration
testing. Mean scores are calculated by summing scores and dividing by number of cases.
For the purposes of this study the two portions of global oxygen consumption are
utilized separately: VO2 (oxygen consumption) and VCO2 (carbon dioxide production).
Each is reported as a range: 0.1 to 1,000ml/min e Accuracy: 2 ml/min plus 7%.
Weir Equation. The Weir equation is the gold standard equation for determining
resting energy expenditure (REE). The calculation of Metabolic rate (kcal per day) = 1.44
(3.94 VO2 + 1.11 VCO2) guides recommendations for metabolic requirements for
nutritional support (tube feeding) in ventilated patients.
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Table 6.
Instrumentation
Instrument

Description

Validity

Reliability

Metaphor*
Metabolic
Monitor

FDA 510(k) pre-market
cleared device. Device
captures many components
r/t oxygenation and
metabolism. This device
will capture 02 consumption
and EE.

VO2 Oxygen consumption
VCO2 Carbon dioxide
production Range: 0.1 to
1000ml/min e Accuracy: 2
ml/min plus 7%

No published data

Lab Analysis of
Serum Lactate

“Siemens Vista” Laboratory
Platform for in-vitro
diagnostics

Serum lactate correlation
coefficient for Siemens
Vista 0.998, R 122

Mean precision
repeatability of
Siemens Vista for
serum lactate
0.03(2.3)

SOFA Score
Calculator

The SOFA score, is the
gold-standard predictive
sepsis mortality index
endorsed by the Society of
Critical Care Medicine

Improved specificity for
prediction of mortality over
SIRS (p< 0.001) and
qSOFA (p<0.001) AUROC
0.753, 99% CI(0.7500.757)

Cronbach’s alpha for
SIRS and qSOFA
(α=0.57), for qSOFA
and SOFA (α=0.28)
and SIRS compared
to SOFA (α=0.06)

Weir Equation
(1949)

Gold Standard equation for
determining resting energy
expenditure (REE) and
metabolic need; Metabolic
rate (kcal per day) = 1.44
(3.94 VO2 + 1.11 VCO2).

No published data

CI 95%

Sample Size Calculation
G-Power sample size calculation yields a desired sample size of 602 using an
alpha of .05 and a beta of .20.
Protection of Human Subjects
This study was conducted with oversight from two Institutional Review Boards
(IRBs). As data were collected from two hospital databases, no human contact was made.
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Data Acquisition Plan
After obtaining IRB study oversight, data were extracted from EBP project
database for metabolic measurements and the ERH. Data were then deidentified and
entered into an Excel spreadsheet and finally entered into SPSS version 23 for statistical
analysis.
Data Analysis Plan
To address Aim #1, means and standard deviations were used to describe age,
weight, oxygen consumption, and serum lactate and frequencies were conducted for
gender, SOFA, and sepsis diagnosis. To address Aim #2, an independent t test was used
to compare the difference in oxygen consumption in ICU patients with and without a
diagnosis of sepsis. Aims 3a, 3b, and 4 were addressed using Pearson r correlations and
Etas. To obtain p values for the Eta statistics, ANOVAs were utilized.
Summary
This study examined oxygen consumption in cases with and without a diagnosis
of sepsis. Other variables such as lactate, demographics, and SOFA score were analyzed
to understand their relationship to oxygen consumption in sepsis.
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CHAPTER FOUR
Results
The purpose of this study was to investigate the relationships between select
available demographics, resting energy expenditure (REE), serum lactate, SOFA score
mortality index, oxygen consumption (by way of measuring V02 and VC02), and sepsis.
The cases for this study were identified via an ICU ventilated patients tube feeding EBP
project metabolic database.
This chapter will present the results the study including case characteristics.
Results will be presented in order of the identified aims of the study. Of the 21 cases,
none had missing data.
Study Aim #1
Describe patient demographics, serum lactate, SOFA score mortality index, sepsis
diagnosis, and 02 consumption.
To address aim #1, means, standard deviations and distributions for continuous
data were conducted. For categorical data, percentages were calculated.
Study sample size was 21 cases. Mean age was 71.2 years (SD 14.1), height 64.4
inches (SD 3.7), and weight 171.3 pounds (SD 51.1). The majority of the sample was
female (n=15, 71.4%). Clinical data included a mean SOFA score of 5.2 (SD 2.2), mean
lactate of 2.8 mmol/L (SD 2.5), and mean Resting Energy Expenditure (REE) of 1,823.4
kcal/day (SD 685.6). Sepsis diagnosis for the entire sample was 52.4% (n = 11).
Next, to further characterize the sample, the descriptive data was compared by
sepsis groups (sepsis versus non-sepsis) (see Table 7 for specifics). There were no
significant differences between the two groups in terms of demographics (age, gender,
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height, and weight) or SOFA scores. Serum lactate was significantly different between
the two groups with the sepsis diagnosis group having higher serum lactate levels (t 3.456 p<0.004). VO2 and VCO2 will be discussed in Aim #2 results.
Table 7.
Case Characteristics by Sepsis Diagnosis
All (N= 21)
Age in years, mean (SD)
Female, no. (%)
Height in inches, mean (SD)
Weight in lbs, mean (SD)
SOFA
V02 in mmHg, mean (SD)
VC02 in mmHg, mean (SD)
Lactate in mmol/L, mean (SD)
REE in kcal/day, mean (SD)

71.2 (14.1)
15 (71.4)
64.4 (3.7)
171.3 (51.1)
5.2 (2.2)
37.8 (11.2)
34.3 (6.6)
2.8 (2.5)
1823.4 (685.6)

Sepsis (n=11)
73.8 (11.1)
7 (63.6)
63.0 (3.6)
161.7 (53.3)
4.3 (1.9)
30.9 (8.3)
30.5 (3.4)
4.2 (2.8)
1582.9 (475.1)

Non-Sepsis
(n=10)
68.4 (17.0)
8 (80.0)
65.9 (3.8)
181.8 (49.0)
6.0 (2.1)
45.5 (8.8)
38.4 (7.0)
1.2 (0.3)
2087.9 (803.3)

Significance
(p value)
.393
.997
.068
.381
.070
.001
.007
.004
.092

Study Aim #2:
Describe the difference in oxygen consumption in ICU patients with and without
a diagnosis of sepsis.
To address aim #2, an independent t-test was used to compare the two groups.
There was a statistically significant difference in oxygen consumption between the two
groups of cases (sepsis and non-sepsis) for VO2 (t 3.919, p<0.001) and for VCO2 (t
3.238, p<0.007). The VO2 and the VCO2 were higher in the non-sepsis group. The t-test
results are presented in Table 7.
Study Aim #3a
Describe the relationships between gender, age, REE, height, weight, serum lactate,
and VO2.
To address study aim # 3a, a Pearson’s r Correlation was conducted for the
continuous level variables and Eta for the categorical level variables. (See Table 8).
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There were strong positive relationships between V02 and sepsis (η = 670, p<.001) and
REE (r = .540, p<.011), respectively.
Table 8.
Bivariate Correlations with V02
Variables

Association
with V02
r = .018

Significance
(p values)
.939

Gender

η = .092

.692

Height

r =.369

.100

Weight

r= .332

.142

REE

r = .540

.011*

Lactate

r = -.329

.145

Sepsis

η = .670

.001*

Age

Study Aim #3b
Describe the relationships between gender, age, REE, height, weight, lactate, and
VCO2.
To address study aim #3b, a Pearson r Correlation was conducted for the continuous
level variables and an Eta was conducted for the categorical level variables (See Table 9).
There were strong relationships between VC02 and sepsis (η = .608, p<.003), REE
(r = .669, p<.001), and weight (r = .619, p<.003), respectively.
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Table 9.
Bivariate Correlations with VC02

Variable

Association
with VC02
r = -.275

Significance (p
values)
.229

Gender

η = .108

.642

Height

r =.299

.188

Weight

r= .619

.003*

REE

r = .669

.001*

Lactate

r = -.258

.258

Sepsis

η = .608

.003*

Age

Study Aim #4
Describe the relationships between age, gender, height, weight, VO2, VCO2,
lactate, SOFA, REE, and sepsis.
To address aim #4a, chi square and Eta statistics were used to determine the
relationships between the independent variables and the dependent variable (sepsis).
There were strong relationships between sepsis and gender (η = 0.687, p = 0.407), V02 (η
= 0.670, p = 0.001), VC02 (η = 0.608, p = 0.003), and lactate (η = O.621, p = 0.003) (see
Table 10).
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Table 10.
Bivariate Analysis with Sepsis as the Dependent Variable
Independent
Variables
Gender

Sepsis
(yes/no)
0.6871

Significance
(p value)
0.407

0.1972

0.393

Height

0.406

0.068

Weight

0.202

0.381

V02

0.670

0.001

VC02

0.608

0.003

Lactate

0.621

0.003

SOFA

0.403

0.070

REE

0.377

0.092

Age

Note: 1 Chi square, 2 Eta
Study Limitations
This study had a smaller than required G power sample size of 602. The sample
was dependent on the number of patients in an available EBP project database.
Additional study limitations are discussed in chapters four and five.
Summary
This study examined oxygen consumption in critically patients using hospital data
bases as the source of data. Differences were discovered between those with and without
a diagnosis. Strong relationships were found between important clinical variables and
measures of oxygen consumption and sepsis.
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CHAPTER FIVE
Discussion of Findings
The purpose of this study was to investigate the relationships between select
available demographics, resting energy expenditure (REE), serum lactate, SOFA score
mortality index, oxygen consumption (by way of measuring V02 and VC02), and sepsis.
The cases for this study were identified via a metabolic dataset that had been developed
for a tube feeding EBP project.
This chapter will present a summary of the findings, limitations, and strengths of
this study. Implications for nursing practice will also be presented.
This study had four specific aims. Each were to describe 1) patient demographics,
serum lactate, SOFA score mortality index, sepsis diagnosis, and 02 consumption; 2) the
difference in oxygen consumption in ICU patients with and without a diagnosis of sepsis;
3a) the relationships between gender, age, REE, height, weight, lactate, and VO2; 3b) the
relationships between gender, age, REE, height, weight, lactate, and VCO2; the
relationships between age, gender, height, weight, VO2, VCO2, lactate, SOFA, REE, and
sepsis.
Summary of Study Findings
Case Demographic Characteristics
The study cases had a mean age of 71.2 (SD 14.1) years with more females
(n = 15, 71.4%) compared to males. Mean height 64.4 inches (SD 3.7), and weight 171.3
pounds (SD 51.1). The mean age and gender split are reflective of the surrounding
community (retirement villages and skilled nursing facilities). There were no significant
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differences in age or gender between cases in this sample with a diagnosis of sepsis
compared to those without.
Case Clinical Characteristics
Clinical variables for this study included measures of oxygen consumption (V02,
VC02), resting energy expenditure (REE), serum lactate, mortality index (SOFA score),
and sepsis. Sepsis diagnosis for the entire sample was 52.4% (n = 11). Specific results for
V02, CO2, and REE clinical variables are available in chapter four. Of interest here is the
mean scores for V02, CO2, and REE for those cases with a diagnosis of sepsis were
significantly lower when compared to those without. Clinically, this possibly could be
interpreted as meaning that despite available oxygen and adequate tissue perfusion,
normal metabolism is altered in sepsis, perhaps reflecting mitochondrial injury. However,
there are no known cutoff scores and/or ranges or standards established for evaluating
oxygen consumption (V02, VC02) or REE in sepsis. This information among patients
with sepsis in an ICU represents a novel study finding and warrants further research.
The mean serum lactate level for cases with a diagnosis of sepsis was higher
(mean 4.2mmol/L; SD 2.8) and significantly different from those without a diagnosis of
sepsis (mean 1.2mmol/L; SD 0.3). Using the 2016 Clinical Practice Guideline from the
Surviving Sepsis Campaign (SSC) a patient would be considered ruled in as suspicious
for sepsis for any value greater than 2mmol/L. The mean score for cases in this study
with a diagnosis of sepsis attained that threshold, therefore it was important that cases
were examined by sepsis diagnosis versus no sepsis diagnosis.
The SOFA score is used to predict mortality among ICU patients. The mean
SOFA score for the entire sample was 5.2 with no significant difference between cases
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with a diagnosis of sepsis compared to those without. A SOFA score of 5.2 reflects a low
mortality index of approximately 15% (Raith et al., 2017). This is lower overall than the
mortality risks associated with sepsis-induced septic shock, which are between 25% and
50% (Cohen, 2015). Therefore, for the total cases in this study were at low risk for death.
The mean SOFA score for the sepsis group was 4.3(SD 1.9), and for the non-sepsis
patients 6.0 (SD 2.1). The difference is not significant (p=0.070), however, it is an
interesting finding as a higher score is generally expected to be associated with a
diagnosis of sepsis.
Sepsis and Oxygen Consumption
For this study, two measures of oxygen consumption were examined separately,
VO2 and VCO2. For VO2. As stated previously, there have been no prior studies to offer
clinical findings for oxygen consumption in sepsis, making these clinical findings unique
in the field of sepsis.
Strong positive relationships between V02 and sepsis (η = .670, p<.001) and REE
(r = .540, p<.011), respectively, were identified, and strong relationships between VC02
and sepsis (η = .608, p<.003), REE (r = .669, p<.001), and weight (r = .619, p<.003)
respectively. Strong relationships were also identified between sepsis and gender (η =
0.687, p = 0.407), V02 (η = 0.670, p = 0.001), VC02 (η = 0.608, p = 0.003), and lactate
(η = 0.621, p = 0.003).
More research is needed examining these potentially important study findings.
Limitations of the Study
Study limitations are common when using a secondary dataset for analysis. A
sample of 21 cases were utilized for this study that were obtained from an EBP project.
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The data for this study were extracted from the EBP project database and EHRs.
Therefore, the data had not been collected for the purpose of prospectively investigating
the difference in oxygen consumption between sepsis versus non-sepsis patients. This
limited the amount of cases as well as the number of variables. Had a prospective study
been conducted, additional variables would have included ethnicity, socioeconomic
status, mean arterial pressure (MAP), and suspected sources of infection and the timeline
for data collection would have been extended to obtain the calculated sample size (N =
602).
Additionally, a selection bias may have been present in this study. The data were
originally collected to determine the nutritional needs of patients admitted to the ICU
who were being considered for tube feedings. Therefore, potential cases where tube
feeding was contraindicated (e.g., nutritionally stable, NPO status, comfort care status)
were eliminated from this study. It is recommended that inclusion criteria for future
studies include a broader range of nutritional status among the ICU patients.
Finally, all reported results for which inferential statistics determined the findings
in this study should be viewed with caution due to the small sample size (N = 21). This
study statistically was underpowered.
Study Strengths
Many studies utilizing clinical data are cost prohibitive to conduct. This study
incurred no such costs because the data were already available. While this study was
completed with a small sample size, there were considerably large effect sizes
demonstrated. Therefore, this investigation has the potential to contribute to the design of
future studies. In that sense, it may be considered a feasibility study (Arain, Campbell,
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Cooper, & Lancaster, 2010). Finally, this is the first study to examine oxygen
consumption in patients with sepsis and therefore, makes a significant first step in
understanding important clinical relationships that may eventually lead to predictive
models to prevent and manage sepsis in critically ill patients.
Study Implications
Sepsis can be especially difficult to prevent in patients, especially older adults.
Sepsis represents a significant management challenge for healthcare professionals,
because it often leads to septic shock and death among their patients. Nurses are
positioned on the frontline level to prevent and/or to be alert for signs of sepsis.
Additionally, they may offer opportunities to slow the decline of sepsis into deadly cases
of septic shock when the appropriate types of clinical data are available (Schorr, 2016).
As this study pertains to clinical observations of indicators in sepsis, it draws a particular
appeal to nursing practice and research. Study implications will be discussed here,
including opportunities for nursing practice and nursing research.
Nursing Practice
Nurses have the opportunity to champion themselves as experts in clinical
surveillance. Objective clinical measures such as vital signs, lab values, wave form
tracings, and pressure readings that are captured daily during clinical monitoring may be
utilized as triggers of clinical deterioration, thus providing opportunities to intervene.
Surveillance differs from monitoring in that it utilizes data in a systematic way that is
goal-directed for the purpose of initiating rapid, appropriate interventions (Giuliano,
2017).
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While this study utilized a small sample, it represents the first step that may
eventually offer a predictive model for sepsis that employs one or more variables
representing oxygen consumption, novel variables. Oxygen consumption currently is
easy to measure; it is already being utilized to determine the metabolic needs of ICU
patients. Practically, nurses could use falling measures of oxygen consumption to
intervene and prevent untoward clinical outcomes such as further deterioration of patients
with sepsis.
Nursing Research
A number of subsequent research studies can be recommended to continue this
study’s line of inquiry. These include further expansion of the study to include more
variables that are often included in other sepsis studies (mean arterial pressure, time to
first antibiotic, survival to discharge) and other variables that might contribute to a
phenotype model (ethnicity, immunologic profiling, and other biomarkers). Alternately, a
larger scale prospective study or secondary analysis of existing larger metabolic-type
databases may offer the opportunity for improved statistical power and the generation of
a meaningful predictive model for sepsis.
There have been no earlier studies identifying measures of oxygen consumption
as a significant biomarker for sepsis. Such a specific biomarker for sepsis would be a
prudent next step. A larger scale analysis could identify a sensitive intercept where
oxygen consumption starts to trend down even prior to the major signs of infection. This
could offer for the first time, a biomarker for an early identification of sepsis.
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Summary
The purpose of this study was to investigate the relationship between oxygen
consumption and sepsis. Secondary databases were accessed for the purpose of
conducting the study statistical analysis. Utilizing these secondary databases came with
certain limitations. However, the study findings did identify a statistically significant
difference in measures of oxygen consumption (VO2 and VCO2) in sepsis cases when
compared to non-sepsis cases as well as some important clinical variables that were
related to VO2, VCO2 and sepsis.
Conclusion
The mortality risk for sepsis remains high, 25% - 50% (Seymour & Rosengart,
2016). Per the Healthcare Cost and Utilization Project (HCUP) report, the average cost of
treating one case of sepsis in the hospital is $45,500 amounting to $1.5 billion annually
being spent on sepsis care (Barrett et al., 2014).
There is no gold standard for the diagnosis of sepsis. The determination of sepsis
is a clinical decision left to the discretion of the interdisciplinary clinical team members,
including ICU nurse clinicians and physicians. In 2016, the Third International
Consensus definition of sepsis was published (Singer et al., 2016). This definition
rejected the 25-year-old notion of the SIRS response and offered that sepsis was a
“dysregulated” host response to infection. No operational definition has been offered to
explain the dysregulated nature of this host response to infection. Evidence of cellular
dysregulation in the form of oxygen consumption may yield a much-needed added
specific and sensitive biomarker for sepsis. This study has contributed some of the first
tentative, preliminary findings to launch further scaled-up research studies.
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